KCNQ1 Variant A52V
Summary of observed carriers, functional annotations, and structural context for KCNQ1 A52V. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT1 penetrance
21%
2/10 effective observations
Total carriers
0
0 LQT1 · 0 unaffected
Functional studies
0
Publications with functional data
Variant features alone are equivalent to phenotyping 2 individuals with LQT1 and 8 unaffected individuals.
In silico predictors
| PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density LQT1 (%) |
|---|---|---|---|---|
| -0.65 | 0.403 | 0 | 0.48 | 22 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. BLAST-PSSM reflects evolutionary conservation; more negative values indicate rarer substitutions. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
| Source | Year | Carriers | Unaffected | LQT1 | Other Disease |
|---|---|---|---|---|---|
| Literature, cohort, and gnomAD | – | 0 | 0 | 0 | – |
| Variant features alone | – | 15 | 8 | 2 | – |
Totals may differ from individual publications due to duplicate patients removed during curation.
Nearby variants
Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.
| Neighbour residue | Distance (Å) | Observed variants |
|---|---|---|
| 52 | 0 | |
| 51 | 4 | |
| 53 | 4 | |
| 50 | 5 | |
| 54 | 5 | I54ins, |
| 49 | 7 | |
| 55 | 7 | A55V, |
| 48 | 8 | |
| 56 | 8 | |
| 47 | 8 | |
| 57 | 8 | G57V, |
| 46 | 9 | A46T, A46E, |
| 58 | 9 | A58P, |
| 45 | 10 | |
| 59 | 10 | |
| 44 | 11 | |
| 60 | 11 | |
| 43 | 11 | |
| 61 | 11 | P61T, |
| 42 | 12 | |
| 62 | 12 | A62V, |
| 41 | 13 | |
| 63 | 13 | |
| 40 | 13 | |
| 64 | 13 | P64del, |
| 39 | 14 | |
| 65 | 14 | A65V, |
| 38 | 14 | |
| 66 | 14 | S66Y, S66F |
| 37 | 15 | |
| 67 | 15 | P67L, |